Avoid Using the Abbreviation "tPA" for Alteplase

You'll hear controversy about whether more patients should receive alteplase (Activase) for acute ischemic stroke.

New labeling suggests broadening the scope of stroke patients who should get alteplase. But this is due to new rules designed to simplify labeling...not new evidence.

Now the Am Heart and Stroke Associations are weighing in...saying yes to using alteplase in more patients...but with a few cautions.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote